Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  Emblem Corp    EMC   CA29082J1084

EMBLEM CORP (EMC)
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (CAD)
Sales 2018 9,33 M
EBIT 2018 -13,0 M
Net income 2018 -8,71 M
Debt 2018 -
Yield 2018 -
Sales 2019 48,3 M
EBIT 2019 3,08 M
Net income 2019 2,16 M
Finance 2019 13,7 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019 53,78
EV / Sales2018 15,2x
EV / Sales2019 2,65x
Capitalization 142 M
More Financials
Company
Emblem Corp. engages in the sale of cannabis to patients who have received medical authorizations to acquire and use such cannabis.Its activities include production and sale of dried cannabis to qualified patients.The Company was founded on February 25, 2008 and is headquartered in Toronto, Canada.... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Emblem Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on EMBLEM CORP
07/18EMBLEM : Announces $3 Million Strategic Equity Investment in Natura Naturals and..
AQ
07/11EMBLEM : inspires Canadians to Get Curious with the launch of new adult-use cann..
AQ
07/11Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose..
AC
07/10EMBLEM : inspires Canadians to Get Curious with the launch of new adult-use cann..
AQ
07/06EMBLEM : Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commi..
AQ
07/05EMBLEM : Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commi..
AQ
06/21EMBLEM : to Launch Emblem Germany in Joint Venture with Acnos Pharma
AQ
06/20EMBLEM : to Launch Emblem Germany in Joint Venture with Acnos Pharma
AQ
06/14EMBLEM CORP : Making Smart Moves for Growth as Cannabis Legalization Moves Forwa..
AC
06/02CORRECTING and REPLACING – Canntab Brings Pharma Standards to Medical C..
AQ
More news
Sector news : Biopharmaceuticals
07/19AMGEN : and Cedars-Sinai in Collaboration for 'Health-Care Quality'
DJ
07/19MERCK AND : to Limit Drug-Price Increases, Cut Some Prices
DJ
07/19MERCK AND : Announces Plan to Lower Prices of Some Drugs
DJ
07/19JOHNSON & JOHNSON : Women who sued J&J declare victory after $4.69 billion talc ..
RE
07/19Barclays Poaches Senior Health-Care Banker From Deutsche Bank
DJ
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/09WEEKLY CANNABIS REPORT : Our Best Long And Short Ideas 
07/06Emblem completes supply agreement with Alberta gaming, Liquor & Cannabis Comm.. 
06/26WEEKLY CANNABIS REPORT : Molson Coors, Shopify, Tilray, Legal Sales 
06/11WEEKLY CANNABIS REPORT : Legalization Is Here, What's Next? 
05/29WEEKLY CANNABIS REPORT : $2.1 Billion Shorts, Hydropothecary, Invictus 
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 2,35  CAD
Spread / Average Target 94%
EPS Revisions
Managers
NameTitle
Nick Dean President, Chief Executive Officer & Director
Harvey Shapiro Chairman, Secretary & Vice President
Daniel Saperia Chief Operating Officer
Alex Stojanovic Chief Financial Officer
Maxim Zavet Director
Sector and Competitors
1st jan.Capitalization (M$)
EMBLEM CORP112
BIOGEN12.54%74 904
CSL LIMITED41.27%66 152
ALEXION PHARMACEUTICALS13.43%30 349
BIOMARIN PHARMACEUTICAL15.16%18 364
GRIFOLS2.52%18 309